BioGenerator

BioGenerator is the investment arm of BioSTL.

BioGenerator produces a sustained pipeline of successful bioscience companies and entrepreneurs in St. Louis by creating, growing and investing in promising new enterprises.

BioGenerator is a nonprofit subsidiary of BioSTL, which advances St. Louis’ prosperity by cultivating a thriving bioscience sector, building regional capacity to capitalize on St. Louis’ world class medical and plant biosciences.

Office
CIC @ CET
20 South Sarah Street
St. Louis, MO 63108

Follow Lewis & Clark Ventures
Twitter: @BioGeneratorSTL
LinkedIn: BioGenerator
Blog: biogenerator.org/news
Website: BioGenerator.org

BioGenerator Wins $750,000 in Federal Funds to Expand Labs and Grants to Build New...

Grant expands BioGenerator Labs and Commercialization Resources
video

Cortex Expands with Re-invention of Historic 4340 Duncan Building

The $44 million, 15-month renovation of 4340 Duncan in the Cortex Innovation District is nearly complete, and demonstrates the connection, collaboration and community partnership taking place around innovation and entrepreneurship in the St. Louis...

VaxNewMo’s Vaccine Breakthrough Published in Nature

The BioGenerator-backed startup and Arch Grant recipient gets highlighted by Nature Communications for its 'promising process' to more quickly and affordably bring vaccines to market.

Galera Therapeutics Raises $150 Million to Advance “Breakthrough Therapy” for Debilitating Cancer Side Effect

The BioGenerator backed startup sees the largest Series C venture round raised by a St. Louis bioscience company.

A “No” from Arch Grants Isn’t a “No” to Your Business

Once you've had a chance to take advantage of St. Louis's other startup resources, talk with your mentors, and strengthen your application, you should definitely consider re-applying the following year.

BioGenerator and Kingdom Capital Lead $2.4 Million Series A Round in Canopy BioSciences

Series A Venture Capital Financing for Canopy BiosciencesStartup to Advance Research Tools Development and Add Jobs
BioGenerator

Local Immunotherapy Startup Attracts $3 Million Investment

BioGenerator-supported Company to Advance Cancer Therapies.

SentiAR Scored A Major Milestone In Federal Grant Peer Review Process

SentiAR, an augmented reality startup based in St. Louis, recently completed a rigorous peer-review panel that ended with a stellar score – and a $2.2M grant. SentiAR's success shows that the medical world is ready for AR, and their startup story shows what's possible when a city shares your vision.
SentiAR

SentiAR Awarded $2.2 Million Federal Grant to Advance Augmented Reality Device for Cardiologists

A panel of cardiologists, engineers, and other experts have given SentiAR, Inc.'s augmented reality (AR) platform an exceptional peer review, leading the National Institutes for Health (NIH) to award SentiAR a prestigious research grant to advance its work to revolutionize the operating room with AR software designed to improve visualization in cardiac surgeries and other interventional procedures.

St Louis Startup Boom Was 20 Years In The Making

"St Louis is really doing it! St Louis has more plant scientists than anywhere else in the world - I think people would be shocked to hear that."
BioGenerator

BioGenerator Wins $300K Federal Grant to Build Bioscience Companies In St. Louis

BioGenerator wins federal grant from U.S. Department of Commerce to accelerate regional bioscience companies.
AgIdea

Biotech Crop Startup Plastomics Raises Investment For Early Seed Round

Plastomics, a biotechnology startup making crops hardier through chloroplast engineering, is pleased to announce the closing of an early Seed Round. Their technology will help farmers and seed companies meet current challenges facing agricultural...

St Louis Bioscience Startup Acquired at $100 Million Valuation

Confluence Life Sciences, the first company incubated at BioGenerator's co-working lab at Cortex, has been acquired by Aclaris Therapeutics.

The Agile Mission of BioGenerator’s Grants Program

An idea is the start of a beautiful thing. But if you don't have the means to test a theory, build a prototype or find out if there is even a market for your idea, how much good can it actually do? Enter BioGenerator's Grant Program.
BioSTL Fundamentals

How BioSTL Fundamentals is Elevating Early-Stage Entrepreneurs

"Fail fast" is more than a buzzword at BioSTL's Fundamentals program, which the organization started to help entrepreneurs identify and push past obstacles early on. Here's how the program is doing just that.
Dollar sign fundraising

12 Fundraising Tips for BioTech companies from Cultivation Capital’s Life Sciences Fund

Bill Schmidt, Managing Partner of Cultivation Capital's Life Science Fund, shares tips for BioTech companies focused on fundraising.
Karen Gheesling Mullis

RiverVest Closes $15 Million Biopharma Pre-Seed Fund, Says It Will Focus on Midwest Companies

Life sciences venture capital firm RiverVest Venture Partners today announced the closing of Archer Seed Fund, LP, at $15 million. Here's more about the firm's investment strategy.
Dr. Juan Arhancet, Apse

Why BioGenerator Works

Any entrepreneur can attest that the obstacles positioned between a brilliant idea and a successful, growing business are many. To startup founders working in the BioTech or life sciences field specifically, those roadblocks can be downright...
BioGenerator

Cultivation Capital’s Life Sciences Fund Finds Sweet Spot

Since its inception in 2013, Cultivation Capital’s Life Sciences Fund’s portfolio of 14 companies and one accelerator have raised $321M in total funding–with a $10.3M total dollar investment from the firm–while creating 180 jobs...
video

St. Louis Startup Accelerator Guide

St. Louis is a hotbed for startup accelerator programs right now, each with features that stand out — such as a focus on a specific industry sector to an emphasis on inclusion.

Cultivation Capital Leads $1.2M Financing Round in S4

Cultivation Capital announced this morning that they have made an investment in S4, a data gathering and analytics company that provides risk management solutions to financial, agribusiness, and farming players through its algorithms.The St....

Founder Series: Steven Hanley of MediBeacon

MediBeacon is a name to know in the STL BioTech sector. The makers of proprietary, non-invasive, real-time monitoring systems for kidney function, gastrointestinal permeability and other light-activated diagnostics, MediBeacon acquired Mannheim Pharma & Diagnostics,...

Founder Series: Joseph Monahan of Confluence

When Pfizer left St. Louis in 2010, A small team of ex-Pfizer scientists with strong ideas for a new strategic approach to drug discovery research partnered with the St Louis BioGenerator leadership to develop a business...
BioGenerator Lab

Breaking Down BioGenerator

What is BioGenerator?  The short answer: A subsidiary of the non-profit organization BioSTL that was formed in 2003 to create, grow and invest in life science startups in the St. Louis region.The long answer: Their...

BioGenerator Company Accuronix Targets Pancreatic Cancer

Pancreatic Cancer causes 40,000 deaths each year, with available chemotherapy regimens providing only an average of 6-11 months survival. WashU-born company Accuronix, founded by Dr. William Hawkins and Robert Mach, PhD. (now of the...
STL Startup Funding

STL Startup Funding Guide

Million-dollar ideas need more than sweat equity to transform into a successful product or service. From accelerators supplying seed-level startup cash and mentorship to private equity firms offering hefty growth-stage investments, here’s a snapshot...
Bio STL Global STL EQ

International Affair

How BioSTL's team is building a relationship with Israel's startups to grow St. Louis' ecosystem.

Disrupting Infection with Nanotechnology and Tom Cohen

Tom Cohen is founder of Nanopore Diagnostics, a St. Louis life science startup that's part of a new wave of companies bringing nanotechnology tools to today's challenges. They’re creating a clinical testing device to...

STL Startup News: Weekly Download – Dec. 11

Here’s a recap of STL startup news this week. Have news to share? Email us at editors@eqstl.com. Growth: Venture Café’s weekly happy hour gathering for entrepreneurs and innovators celebrated its 20,000th visitor on Thursday. The gatherings held at the @4240 building in...

Why All Wine Drinkers Will Love StiQit™

We spoke with Alan MacInnes of YourBevCo about StiQit, and how it will impact all wine drinkers.

Can St. Louis Become the Next Bioscience Hub?

The growing list of bioscience companies bringing their research and operations to STL has forced many to take notice of the city's place in the industry's evolving landscape

BioGenerator Gets International Nod, Arch Angels Flying High, Appistry’s Samson vs Goliath Legal Battle

A compendium of St. Louis Startup news, celebrating America's most innovative entrepreneurs.

St. Louis Startup Scene: Gabe Lozano Hacks, Girls Ask Guys (Guys Say Yes), Sparo...

A compendium of St. Louis Startup news, celebrating America's most innovative entrepreneurs.

St. Louis Startup Scene: Capital Innovators Fund Five, DreamfundMe Makes It Personal, T-Rex Parties

From rapid expansion to a rooftop end-of-summer blowout, the St. Louis startup community moves onward and upward.

Startup Scene: BioGenerator Expands, SixThirty’s McKelvey Looks Overseas and Two VC’s Get Props For...

Startup news about BioGenerator's huge expansion, Cultivation Capital and Ascension Health's Big Dough, SixThirty's oversees search and more.

St. Louis Startup Scene: Square’s McKelvey Launches Launch Code, Showtime Signs On With LockerDome

News about Jim McKelvey's "game-changing" announcement, BioGenerator's new entrepreneurs, LockerDome's relationship with Showtime and more.